News Focus
News Focus
Followers 142
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Cardiologymd post# 196819

Friday, 06/14/2019 12:43:55 PM

Friday, June 14, 2019 12:43:55 PM

Post# of 447398
C-

To avoid any doubt: I did not question your experience … but you questioned JT.

That doesn’t correspond to reality.

How anybody could think that JT said what he said without any background / info?

As a new drug, we are starting off with the already having pretty good managed-care coverage, considerable portion of our prescriptions currently are off label and the approval rate for managed-care is just a shade under 80%, little over 90% of adult lives on Medicare Part D covered by insurance predominantly tier 2, predominantly unrestricted, and about 80% of lives on commercial insurance covered by insurance. So, again predominantly tier 2, predominantly unrestricted.

It is the reality … which isn't equal with your experience … but nothing is wrong with it.

They have an up-to-date database for every plans.

Best,
G

"There are some things money can't buy. For everything else, there's AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News